                           ˿µϣ20110824գ

11.08.22-23ûи
11.08.24, ӡʳᡰˡ𣿡
11.08.24, ˴աѧٲӦѧ񡱣ۣ
11.08.24, 쿪򡶴Ӻ¼̸йĿѧĳ·
11.08.24, 㡶ҩĿѧоᱮ 
11.08.24, TanPPйԺʿѡˮƽ빱Ӧøĸġ
11.08.24, С廪ѧڵѧУġ̡
11.08.24, ˡǧ˼ƻѡߡ
11.08.24, ȫְڿNSFCϡɽࡢɽʡ̩ɽѧߺƸ
11.08.24, ݾüѧкʿΪٱ
11.08.24, ±ڡʦƳ ʦ±١һĵĲ䡷
11.08.24, СѣΣ
11.08.24, ŹҫҽǵʶԴ
11.08.24, 걣ҽѧĹϵ
11.08.24, ƽ̸̸ӴٵġΧ

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

                 ʳᡰˡ

                   ӡ

һѧʳõġʳˡʾơʾʳ
СʱڲͬʱʳãᷢжΣգзӡ
ӡϻṩԻˮźڻƤȽⶾط֪
Ϊֻгзʳġˡ˻ʳǲǶз
飬´Ҷз

ֻǹΪġʳˡеһС֡Ȼҽ
ʳˡҽйأҽ伮кܶⷽļء硶ݸ
Ŀһڡʳɡо180ԲͬʱʳõʳЩһ
֪ڻţ硰ţ⡱еţ
Ӽͬ˼ǼܺļһԡΪʲôļͿԣ
ûееΪ硰зӡмָۡ
ʳˡûпѧݣֻһź󣬾˵˳з
ӡкͷۺжģս˵һ

ҵȻԡʵԹ1935꣬Ͼ䴫˵㽶ܵ
ʳ˶жﻯѧ֣ȤѼ184ԡˡ
ʳѡ14ճбȽϣ󡢹ͺ
ʵ顣˺һͬҲе7ϡʳ24Сʱڹ۲ʵ鶯
˵ı顢Ϊ¼ɫȣûжļ
֣ġˡʳУͰзӡ֣ۡ
ٵĿѧ֮һ110ꡣ

йӪѧֱݴѧѧԺҽƴѧ
˸ϸһЩġʳˡʵ顣ݴѧʵѡ5鴫˵˵ʳ
ϣ100־Ըʳãһܣûзһʳ
ҽƴѧʵѡ12ʳϣ30־Ը3죬
Ҳδ쳣ֻ־ԸΪʳ䲻¿ζʺϡ

Ȼûжд˵еġʳˡȫʵһ飬ǼȻѡ
31鳣һôûʣµĲϷ
ˡ˵Ȼʱû£᲻Եжҽ伮
䴫˵ġʳˡָǳԺϻֵļжˣ
ָжͨԷּжܷжʳ
ɵҪʵ顢ٴвѧܷ֣
ûûšʳˡᵼжҲ˵
ʳˡָͬʳһпƻʳеӪɷֿ֡
ԵȻڣ봫ͳ˵ġʳˡһ£Ҳⷽ
ʶĳʳﵼӪǲͨ鷢ֵġ

ȻԡʳˡŲɣΪͬʳеĳɷǿ
ѧӦġʳɷǷѧӦǱָʵ֧ŵģ
뵱Ȼط̸Ϊзˡԭǡзںз
ĵʣӵ׳̳ɲʣ
ãԣҺķڣʹڳڷͣ
ʹʳ߳Ż¡͡кʳж󡱣һұֽĽܣ
ܳĻôӲзˣߵʳƷ⡢
ţ̣ˣκκ׵ʳƷ֮ˣĻӾͼ
ʳƷˣʱٳԱĶˡοз
ˡ˵ѱʵ񶨣ûбҪΪҽˡ

еġʳˡ˵ǽųֵģ硰ϺάC
άCĹ֭ͬԡϺһŨȺܸߵġ黯
޶άCתɾ綾ġ顱Ҳ
˪жˡǰһѧڱͲʱͻļ
Ϊṩ˳Ϻˮжġʵ
Ϻ󲿷ȶл飬޻ĺܵͣ4%ұ
׼ÿǧϺ޻麬ܳ0.5ˡʹЩ޻ܱάCȫ
ԭ˪̫ܣôҲҪ106ǧ˵Ϻܴﵽڷ˪
ޣ70ˣ53ˣûѾˡ

ʳˡֻйе˵˴ûⷽĹ
ҳԣϽ֭ˣĪй
壬ʳֻйˣеʳﱾһĶԣжĻķ
ۣеʳԻӣʳĳЩϸȾ
ʳж˶Щһ֪һĳʳк
ͻ뵽ǲΪʳˣԶﴫвޡ
ǲҵģʹ˽ϳֵķ֤ݺȻҳֽ
ȥǿ顰ʳˡʾûôժġ

2011.8.22

й걨2011.8.24

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ӰϷҥڷѧˣزǡ˹ɡ
ҵԱڡϷб£˸˵зѧ
ٱѧǰ졶Ϸб߻Ҫ˿մġ
󡱵ļ٣ûǣԺƼȥһҴ٣һ
Ҵ٣ΪҺһ˸ѣ

λ̽ҵԱ˵ꡰʵѧ٣˽ԿΪ֮Ҫ
ʲôʸ񡣡˵ңʹԼҵﻯѧרҵҲɥʧжѧ
۵ʸˡ˭ʸپûʸϷҥǶ˲
¡

ѧٲӦѧ

20110824Ϸб

֮ר

ѧٵĴ﷽ĸУĽָسϮ
ȨЩ˶ԷǷѧʸ顣ʵѧ
٣˽ԿΪ֮Ҫʲôʸ񡣷ʹԼԻַ
ȨĴҲӰԱ˵ѧΪнҷЩ
ͼҳӱѧ۵񶨷ӵĴ
ҵ߼ǲġ۷ӵĴ٣ӦĴҵ


ôԴҵӦȥأΪӦǷѧ
ȥۡѧٵĿģΪ˾ѧ磬ԴΪܱ
ѧ񣬷񾯲ִȴ˷һʲôѧʱо
ѧѧҲάҲɴѧѧѧķѧߡҴǳ⣬ѧ
޷һǿѧѧĵѧҵĿ
ǣԷΪġѧ١Ѿѧ

ҽҪ̸̸ѧѧѧȾϸĹ۲ʵ
ֺȷʵѭϸ߼ӹ۲ʵۣ
ĽѧͬйԴɹʶѧٱ
ǿѧоһҪϸѭҪͬ׼ȷʵ
ϸѭ߼ѧ繲ʶڣӦǡֵġ

أʵ϶ϣӴپν֤
Ҳ˵ֻһϢԴľٱϢʵĹ
óȻ㹫ݴָйʿ١˽е˶ֻ֪
ܹȶظɲͬоԱڲͬʱص²ȶظ
¼ܱ϶ΪѧʵȻûôϸ
һҲų⡰֤ѧԭҪȱȨԵϢҪ
ϵϢԴʵġ١վϣ£ǧ
ƣһֱڴֻһԴνϡ˵
ȱѧ̬ȣ˵˾ӹҥԡΪʵ϶
൱ʣĴҲʵϵĴǰһ˵
Ĵԣָرں20ûзһƪġǰ
ý屨һСμתͶ϶֪Żչڡѧ
ſڿƭڡ

ٿ߼˽ѧѧˣ֪ܶѧоѭġ֤
༴һؼʵ󣬾Ʒȫۼ˵ƵĿѧ߼
ҲӦ򡣱ҵ˾ʵУطֻҪ֤һ
ؼ֤ݳȫָؾͶᱻ񶨡ڷӵѧ١
УΪԼŪʵʱطԷ١
ָء෴ҳġʵָԷ١磬
óԼ20嵥֤ӡ20ûз
һƪġָٵ֮󣬷ȴת⣬ʼָЩ
ﲻѧĵˮ׼ӵ˼ά߼ȫһ
ܹѧѵƲʿЩαѧоߡ
Щ˼֡ƽġѾ͸ۣ֮оٳ
ʵ֤ݡٴ֤ǵĳʵǴģҲ
ҳʮٸġʵգ㲻òۣ
ʱʵ֤ƽġ

ѧôѧٹӦѧ
ڷһûд¹һѧо(ֻ
ʿ)ҵѧ˵ʹԼҵﻯѧרҵҲ
ɥʧжѧ۵ʸˣҪ˵Щеרҵ
ȨκרѧɣжӦͬרҵѧʵͬ
רȥҲ˵ȨҽҽǷαѧӦ
ҽѧȨʿ϶ȨɺǷˮ
ƽӦɷѧȥ϶ӾԽѧơ
ڡαѧǸǺ˵˵֮ԡⲻ
һؿѧͬԭˣȴЩҵˮƽͨ
ʿսһרҵȨġơǡ

ѧһ棬ı۶ֵȣҲ
ȱϲڱʹôɫʵĴʻ㣬ϲѷ
ʿΪĿɵ椡ѧƣŮԡƪ
Ļ⣬Ҳ׸ˡ֮ӵν١ѧ̫
Զʹʵࡰ׼ˡİҲ塣Ҳ
ܡκá˵ĲǵķȻΥѧΪӦ񶨡
(ϵ̽ҵԱ)

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

Ӻ¼̸йĿѧĳ·

ߣ쿪
2011-08-24۲

գ֪ѧ˷ӲʿڲָѧԺ֪ں
1993ûзѧģоʹѧĽڡһָ
м˫֧߶ݡ

ںӦ֮ǰ֧ΪһڣӦֻģ
ҪӰ졣ߴԵڶ籨¡
ӶԺе𣿡ɽѧԬΰʱƣ˹
ҷǳ󡣡100ƪνҲȲϺΪζд
һƪ»š

ΪϺշȷеӰ죬
ΪΪоʹѧĽڣ䱾ְӦýѧͿУ
ǱĩáȻÿڶԴΪɶѧо
ѧ۾޴̸ˡ
󣬺䲩͹199040ƪ£Ϊ
ӵ֤ݣ΢ԣԺڷĲȡ΢Ŀѧ
ڿϷ۾Ϊġ󣬷΢ָѷ
塢Ի¼ʱ̸ȫġл
лѧԺҽŷѷһǧƪģ

λʵѧо۵ľ޴ࡣΪ
ܹϸѵѧߣ˽һƪѧĵҪǷǳϸġһ
˵һƪѧģƻѧҪϵͳ漰
оͳɹνȻֻʲô
оִоȱݣӶȷԼоıҪԣŽܱ
оϵͳѼݻϣȻоĽ
оʵ壬ָͽоķһƪϵ
ͳ£1ֻӡˢ20ҳҡڵĿڿ
Դһġʽȱϵͳ֤ʽ£Ҳֻô36
ҳֽҲ롰ѧġ֮Сڼʱν
Ŀơġ̾ѡ

Ĳ࣬ٿģҲλˡ
ѧı׼ߺ˶Ժ䲩г9339ƪ
9092ƪȷʵѧģָص93ģ
ԷΪࣺȣ5ƪ͵23ƪѧģѧڿģ
ΪǱԱжǾͬä󷢱ġΣֻе6
ƪ͵36ƪѧڿϵоѧġ£緽
˵ģ£оѧġгĵ4ƪ
ţɴǵ䡷ȽϷо19933ڣ105109ҳ
һƪģӦϵͳ֤ɷ룬ǽѡȡ
ͳһƪѧġٱ10ƪν
ߡѧ19975ڣ58-60ҳ3ҳСۣҲ
һƪѧġƵ»кܶ࣬12ƪ    ɡ
˽Ȩġ19976ڣ45-47ҳ˽
ӵ漰Ŵ뷨Ŀ⣬3ҳֽܶ롢
ϵͳĲҲֻһƪ򵥵ĸʽۣһƪѧġ
13ƪʮ귨ƽ벻㡱ⷨѧ19985ڣ8
11ҳҲֻǸܽۡ

ڲṩӲɫǿȽ͵һƪӢ
£39ƪ4ҳThe China QuarterlyҲһƪ¡
ڿںĵһ˴ı⡰Article Commentary
£ÿ·ֱˡArticleģ/Research  Article
оģResearch Reportо棩Article Commentary
£Book Reviewɼͬ·ȫͬ
оģᡣѧҲż3-5ҳ
ۣѧߵֻһֿп޵ĵ׺
ҪоԵѧġһѧ߼ʹϰƪº
û㹻оѧģܱΪڸ˵ˡѧԼ
ļְƿУԾذºг
оķһԱ⣬ѧб¼Ҳᵥ
гΪЩûڿϸä

ΪҲйõоʹѧԼо
ϵͳоܳѵˮʽĹڼ򵥵ֻۡ
ѧİɾͿԡġġȻں
һѧѧѵ80ɣҲûжʿľ
Ҳܹġ

һ¼߾бҪѧԽڵϵ
ȣ3000ѧֻ250оʹѧҲʸպ
ʿĴѧҪѧоҲ250ѧ3000
ѧڽѧֻͣеƺ˶ʿӦأ3000ѧʹѧ
ԽڵҪԽѧΪоҪܵûУڵĹѹ
оʹѧСоʹѧҲӦҪЩѧҲЩ250
оʹѧԽڵۣҪоΪоҪԷڱ
ѧڿϵۣڿĵκӰӡһ˵
ղʿҵڣÿҪڱѧڿ1.52ƪҵ£
Ӧ2ƪϷڿ6Ϊڲͬʱõ
ڣtenureְλˣﲻҪ뿪ĴԼռ60%
пᣩӸΪڣҪҲˡЩõְλĸ
ںͽڣȻϯǿԲٷ£ǣûо
µоͬûвʿָҲᱻͬ±Ӻͱ
ۣҲԾؾѧģϵ60
ͬ¶ڼѧġ

оʹѧͽѧʹѧͬϵԹڵĴѧн塣
ڹڶʲôεĴѧҪʦǷģǶʱԴ
ľ޴˷ѣҲڿ͵Ϯķġһеİ취
ǻ200ҴѧΪоʹѧѧΪѧʹѧȷͬ
ϵԽѧʹѧʦ90%ĿԽѧΪѧֻռ10%
ͣͣרҵԲǿۺڿʡжΪĳĳѧ
ڿڿıίûרҵ
ߵרҵڿѹڿÿڵ5-8ƪ
ڣĿѧڿˣϸȡäƶȣ
ͱίѡֻܽѧڿߣֻ
ĵԷġ

ΪڵĳĶ࣬;ԼǱ
֮ʵһִ˼·ڹѧߵѧУ
ϵͳоĸ¡ԼһˮƽĽڣ
Ӧþҵҵءʵѧоģѧ
оʹѧ֪Ӧþеķ緶Ϊоʹѧ
ȴԸǱĴѧоǶѧԴڸλ˷ѡΪڣ
Ҫ֪ƽѧ롣߷ѧҲһǱ򡱣
Щý֪ԽѧߣѧˮƽôΪѹʱ
Ĵݽýͷ¶棬ѧʵʱҲͲˣѧˮ
ƽȻҲͲˡѧ죬ˡ

߼飺쿪մѧѧԺսԴϵ/ý봫
ʿĿ 

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ҩĿѧоᱮ 

ߣ

йʹǧĴͳҩִܷĽйЩ
˿ܲΪֻ⣬й磬ҩδΪҪҩԴ 

ҩֽȻ෴ļ˼һΪҩִҽѧй
ԺãһΪҩִܰѧ׼Сҩ
׼ 

غķ֣ǳؿ϶ҩ࣬һ
ĴͳкܴǱƽ 

ع˶ǵо̣Կ˼άĴ󣬶Ե˼ά
м·ȴǺġҲǽı֮·غ
ִѧķѭִѧı׼ǾʱĿ顢
ͯͳ˵ 

ҩﶼԴҩλӽĿѧ1970
֡ڴ͡523оűҩУҽоԺҩо
ǷصĴԸСģʽ̽Եоҩ
ùУҽƴѧһҽԺͤ˪
ѪõҪߡ 

Ϻ֮ǰ¿˻1920ڱЭҽѧԺڹڼ
ҩҪ֣رعܵо⡣ڵЭ͹
ǰ¿˻ѧѧúܺõĿѧѵЭ͹Ժֻص
ѧҩ﹤ҵ磬رҩѧ磬¿˻ʡ 

1950йչʮꡣڱϺ͹
ͤûпԺͳ¿˻ȵѵǷֱ1950Ͷڱҽѧ
Ժֱҽѧ͹ҽƴѧڴ¹ؼʱڵĹҲ
Զ롣1960кں1970ڣйڡΰ޲׼Ļ
ȳУйʷصĽ׶ΡھЩй˰˶˵Ӹ
Էӵ쾡µļꡢڽйѧԺʹѧоĿѧҺͽڷ׷ױ
ţͿվ󣬵1970ѧлܶ˶£
ÿ칤ʱҪǿֻ4ġձȱЩŮѧ
ʱҲϰëµУоѺͿпǺ١ʱ
£ȻҪķ֣ҿйҪҩ﷢֣
¼δͶҩ￪ĽйҽҩԽ 

϶ϿϺͤĹعǵĹ壬
ұϣܹ̼˸ϸоܽľֵüȡ
ѵٽйҽҩõоͶȻЧ̽ 

غ 

ڲ֪أartemisinináЧĿűҩ
һʹãҲڶҩ୳ֿҩ£Ըõ
ҩȻزȱ㣬ҲǿűҩΨһҩ
ǣȷʵ˺ܶಡˣʱáڽṹϣ
ȫͬűҩȫµһҩȻͼѰҸõ
ԱĽЧٿҩԡڿѧϣõĻδ
ȫȻо⡣ 

صķ֣֪Ҳ٣нϴۡҪһǣ
ǷΪ 

523ëϯܶӦԽϵҪҲй
ű⣬ʼȫԿűоƻ֯ʼΪ1967523գ
ĸпᶼҲȵطʱ֯ҪЭ칫һֱھ
ҽѧѧԺĵλ鲼ȫܶطϺϡɽԱ
ټˡʣһģĿкܶ˵ļ
áǣǷд˭Ǵ 

1930ϣ19511955ͶڱҽѧԺҩѧϵҩѧרҵ
䵽ҽоԺдѧѧλ1969걻ټ롰523
񡱡 

523ƻֳɼֱ֣ҩķƷҩ
Ѱҿűҩüҩ棬ͬ˺ܶҩҩЧ
ǿýϴĳɽŴҩϣ5060й
䶼ʹļ¼ҽоԺҩоϿǸ
ܵĿűҩ808ͷ÷סȡҽѧѧԺ
űģɸѡ˽ٸҩȡ60%~80%ʣȶ
ϸṩɸѡ˶ҩ嵥ҩƵۻơơ
ɰȣҩ󸾡ɡɽסµȣֲҩعƤ
𡢻ƻ⻨ѻӡ޲ݵȣϿҲ۲쵽Ч
ˮЧ95%ҴȡЧ۽30-40%1971꣬ϱ˵һ
ؼȡȡ￹űô95-100%һ
·ĸЧԡ19723£Ͼ523Ļϱ
һôע⣬δΪΨһص㣬ܽʱ߽֯顰ӥ
צҪⶨѧṹкϳɵоɺײٽһ϶Ч
ٴЧĻϣ廯ѧṹصҩڿ϶ٴЧ
ͬʱӿ쿪չЧѧɷֻķȡ 

Ͽ鹤ĽͼеĻԻ
Ժԣسɹػؽᾧȡ÷ʽϿԱЯ
أ飨йѧԺϺлйѧԺо
ȣΪطӡؽṹڻ֪С1972
£ɽ没оɽʡҽҩоʡҩо
ȡɽʡҽҩоʡҩо˿
űЧ壬ֱΪƻءɽ ءϣ
1974꣬ƻغͻضΪǱء 

Ȼʷкۣܶǣ1ȡ
ȡڷáͽһоﶼܹؼ2봿
صԣأҲϿĳԱ3ȡصС
ڹϵ֪С鷢Ժеġ 

йصʷع˺ܶ࣬Ľȷһ⣺ȷʵ
صķֹ˹ؼáͿѧңȷʵ˺Ҫã
ϵĹǰ˵ĻҲԱҪá϶ò
û˵áӦиϸʷأ֪523֯
ҪߵĹס 

˪ͤ 

˪ĻѧɷΪᣨ飩 

˪βҩдͳҲùҩ˪ʯۻơ
ƻƵȡεġ궨ݡʱġݸĿ˪ҩԡ
ʮͺͶʮʮҲưѪδձ
ƹ㡣  

19713£ҽѧԺһҽԺҩʦ̫ƴҽ֪
˪ۣȻǹܵܰͽ˺Ͱ֢̫ƽˮ
"713"""עҺͨעΰЩЧ̫
± 

ҽƴѧһҽԺҽƵͤ˹ͤ1950
ҵڹҽƴѧʮμҽѧҽѵࡣ 

1972ͤһ濪ʼҪѪѡ̫
һǽֱַ⣬ֻҪ˪Ч۴
ԡִѪѹĸá߶á 

1973꣬ͤɡʡ̫ڡҽҩģ
áעҺԺҲơ1ţ6Ѫˡȷ
Ҫ˪Ļѧɷ֡ᣨ飩΢ۣȻع
6ϸ԰Ѫ˶иƣһмԱĻҲЧ
ᵽоԼ԰Ѫá 

1974꣬ԹҽһԺҽƺ͹ҽһԺڡҽ
ѧѧ1עҺ֤ζ17ѪЧ۲족ܽ
1973119744¶Բͬ͵İѪƣ֡1š
ְѪЧԼ԰ѪԴﵽȫ⡣1976ҽһԺҽ
׫ġҽƼ԰Ѫȫٴʵ1979꣬ٸ
ͤڡҽҩ־1ƺ43ˣ
Ϊϸ԰Ѫ 

1979ͤٸڡҽҩһעҺ֤
ƼϸͰѪܽ19731978ƼϸͰѪ
ܹ551973197423ðһţ19751976ðһż
2019771978ðһż12ÿһ
ǶͣȷЧ۲졣ȫ55в̶ͬȵĺת
70%12ȫ⣬Բ˵ĶСǻʮڳ˵ļ
12ֻע䰩һţδġΡƢá 

Ҫ⣺1ͤǷȷ֪ư֢Դڡ
һšͬʱʹõҩͻҩ2Ƿʶһ
ŵԴ飬ۣ3Ƿ֪
ϸѪã⣬1979꡶ҽҩ־У
Կͤٸȷ𰸣1ˣһλˡλͯ
ʹðһţҩûҩҲʾЧеʱͯ
Ѿ4꣬Ѵ9£2ڵ11ҳָһ֮Ч
Ϊ顱ҩΪȷЩҩưѪ
֧Ų״3ڵ10ҳ͵11ҳָȷָ
ͰѪЧá 

˵1979꣬ͤͲͬͬºģص춨
ǽʶưѪرǼѪacute 
promyelocytic leukemiaAPLҲȷ--Ӣ͵M3ͰѪ 

1981ҽƴѧһҽԺҽ ָ:ͤ;ִ:Ԫ,
;μ:,,ٸ,,,ϼ,Ѫоң
ڡҽҩ1Žϱ֤ʩƼϸѪ73
СᡷһŶԼϸѪȫʴ24%ܻʴ86%
1982ȫҽϰѪ̸ϣͤԪƹˡ1
ƼϸѪٴʵо22ȫ͡98ܰϸ
ѪٴЧ̽֡ 

1984꣬ͤԪڡҽ־1Ƽ
ϸѪٴʵоܽ1972Ƶ81ϸ
Ѫȫ22ָȫ22У7ΪM2ͣ
15ΪM3ͰѪAPLҲָM3ЧΪ1985
ͤ׫д1ţ713עҺƼԷܰϸѪٴ۲켰ʵ
о 

1991ڡҽҩϢ־¡ᡢͤٸ顢
ջ÷۷1Žҽ֤ʩμѪ
ڴ16桱Ӧ1984ͤԪеĵ졣1991
ָǴ1974굽1985԰һƼѪ3219ȫ
⣬16 

1992꣬¡ᡢͤڡйҽ־
1Žҽ֤ƼѪ32Ϊ齻
ܵȫͬ1991ġȽֵǣӢ׻ƪ¡
ƪҲģ1991ļ飬ʵʷ1973£1979
ȷAPLá 

ͤоļ 

ͤȵʱоûжաΪǲ֪Ǿòò
Ϊգ1982꣬ͤڡҽ־£ʾ֪
ҽѧоĹ淶ָڽؼĻ߽飬ʹǽ
޺ġհ׶աҲǲģֻƽΪϺõƷƷ
չ۲졣ĳЩԡҲԲѡö飬Լ԰Ѫ
ȣҲ˵˵Щ˽ܡЩ˲ܣ
ĵ 

ҽǷưѪָãǽ츴ϰ
ЩףԿҽ֤ͣưѪû塣磬
̸Լ԰ѪҽΪͣʱʹ鲢޲𣬶
ҩҲЩã֤ã
ҩҲԵʱҽ͵ûȷҽ԰ѪķͲ
ҵӦ֢áȫҽ֤ԺӦ֢Ч
ȷСȤǣͤɡʡ̫1973ĵһƪȫ
û̸ҽۣƪĽҽ֤͡ 

йڼѪƵĹ 

ѪAPLΪǰѪȽһ֡1973
꣬BernardƳҩƴʣĽķΪ
Ʒ1973ͤȷᣨ飬As2O3԰Ѫ
á1979ȫӦ֢ΪM3ͰѪҲAPL 

1983꣬Koeffler ܽ˶ֻάᣩϸ
Ѫϸķֻá1983꣬մѧFlynnȱ13-˳ά
һAPLˣ԰Ѫл⡢ԭȥ1984꣬Lund
ѧҽԺڿƵNilsson13-˳ʽάһAPL1986
Daenenȱ˳ʽάһAPL1986ǴѧFontana
13-˳ʽάһAPL 

1985꣬Ϻڶҽƴѧȫάһ5Ѫͯ
1987Ӣİ桶лҽѧ־ȫάᣨϲ͵
APLˡ1988꣬ѪҺ־ģܽ
ȫά24APLˣȫ⡣ƪģʹйҽ
ĿȫάưѪ㷺ӣڹϿõظƹ㣬Ϊ
APL˴ 

1995꣬žҽѪҺרĻ֡ϼ
ҽƴѧһҽԺֻ浡ڡлѪҺѧ־
ƬΪƼѪٴо, ԸƬ60APL
ȫ98%ҩ졢̫ӲΡΡۻƣۻƵ
á 

19962£ҽƴѧһٴҽԺҶ
лѪҺѧ־ڶڷעҺ72ϸ
Ѫܽ19921995üΪ飨
130APLһƳ̵73λȫΪ73%
ȫΪ52%ȫʽά޽ҩ 

199681ѪҺ־¹ǿʯѧ߽ٺ
ܡSi GYС⡢ɡ־顢GL
ͤG Claudeꡢ塢õĺġıá塢
ȴϺѪҺоѪϸ
Ѫõķӻо 

1997꣬쾴,,Ө,,,ͥڡйѪҺѧ־
һηAPLˣÿðһţ20 

1997꡶ѪҺ־־顢¹ǿ߽ɡģ
ô15APL10ֻ飬ȡ90%
ȫʡ 

1998꣬Ȩҽѧ־Ӣҽѧ־λŦԼ
Sloan-Kettering֢ҽԺͿζҽѧԺSoignetȵġ12
ƺ󸴷APLˣ飬۲쵽11ȫ⣬
ϸַֻϸйء 

ӴˣҽѧΪAPLá 

ٳδͬ 

ϺͤоɹʹڶϿɣõӦãֱӲ
˵Ч 

ǣڲͬԭ򣬸ûлйֵϿɣҲȱʿ
 

صķֺӦãΪ֪ϵĹףȴһֱ顣ԭ
ʷѧϸԿЭġһǡƻͬ
صоͷβìܣ֮ͬìܣڲͬ
֮ìܡʱоԱΪĸԭһʶȽϵͣ˿
Ҳ໥дʱ淶Ӣĸͺ
ءԼȷ˷ۻٺܶࡣ
ȻԿԱãڲ˾ͲһãҪһҷģ
ҩʱЩ˾ͲҩЩܾͲˡ 

ͤȻŦԼʱδܵйĳֿ϶ڹѧ
ҽѧҲĬĬţԭìܡĿ飬˷ìܣ
ںܺ档1973꿪ʼУͤĹؼúδܺ
ϿɣڵйأҲӢĽ١ȱҰ͹ʽ
йءȫųûгʶ乤ҪԵĿԡ 

1998꣬ڡҽ־¹ǿꡢ塢ר
̸нܡ70ڣҽƴѧ¼ƹҽʵз
飨飩ƼѪAPLЧ
ҽӦעҺ֪ȫʽάᣨATRAͳ滯
ҩõAPLˡ϶ͤĹ 

Ӣף֪ͤĹؼãõײ̫
֡Ӣײ֪ͤưѪй
1973굽1979ͷܶӢףѧڹⷢף
͹ѧߵףưѪķֶΪ19921996ꡣ
磬ظйҲڽйƵ1998Soignetȵģ
ժҪ˵йƪAPL£˵й
APLȫ⣬Ȼµ1992꡶ҽ
־Ķƪ齻1996꡶йѪҺѧ־־
1997꡶ѪҺġ 

1996꡶ѧ߶ĽܣȻͤ˵
1992귢ġ 

ͤ˺Ӣġ2001꣬ͤͳ¹ǿΪͬһߣ
Ϊ֡塢ꡢãͨѶΪãڹڿ
ģ飬УҲAPL
ãó¹ǿ1996꡶ѪҺġڣ˵оʼ
1971꣬ûףųһǧ಻֢ͬĲˣ۲쵽Լְ֢
ãϸѪܰʳܰرAPLҲ
áȻ˵APLõĳ1992꣬µġ
齻ͤΪһߵӢ¾ûԼ1970
ļƪףԼ19731974깫԰ѪЧ
1979ȷAPLЧõķ֣ȫûˡ1992ģڱ
ϣ1979޲𣬼ûиıõҩɷ֡ҲûиıӦ֢ 

2002áLallemand-Breitenbachde TheڡȻ֢
˪ʱͼʾ1970̱ͤã
µ1992꾭ܣע֤APLõĵһƪ
ģ1996ȵġ 

Ϊ19921996ƪ£û1970ףԣ
ѧһ㲻֪ԭʼס 

ͳ2008ڡѪҺ־APLоչ
ְ֢ƣΪ2002¡APLΪ1992
µȵľ齻Լ(1996)¹ǿ(1996)־(1997)
ţ(1999) 

ͤúͷڹδõӡ 

϶ͤϵ 

й϶ͤϵȣǶǳٵĸлҲй
ʶҩδֿı⡣ֱϿоȷ
ܻá֢оͰΰʳܰθ᳦ܰ
ȡ磬1981ڡʡҽѧѧ鱨ܽ42ԭ
ΰãһżΪ42%5泬5
꣬Ϊ8%޳5ߡ1988Ԫơͤ
šڡоϸ۲쵽һŶԸΰ
ϸϵá˵ϸоҩɷֵãܻи෢֡
йһЩҽԺģģõһЩҩͺܶҵزִһЩҩ
ϸ飬Ӧ֢ȷܽܣʺϵĲ˲ܵ
 

оغ͡523ʷ˽йѧƻЭ
ȱ㡣һǡǳɹӣصľ鲢ͬһǡ
ʱб鲼ȫġװ칫ҡԷĲȿ⣬ķѵ
ܲ¡523ֲֹۡȡЩľͽѵ
ĿǰĶĿҲ档 

 ʵ 

ϺͤйձϿɡĿ϶ϣ
йڲܼ򵥵Ӣ۳ݣΪˡǲǣҲûǡ 

ǵĹǰ˵ĻԼߵĹסطֹУȫ
񣬺ܶ˲ˡҪסϿڲԱҲ
ҪסΪ϶Ͼͷ񶨿ԱĹס
ס 

вܣǲŻڣԼںʵĹϣ
ùҪ֡ 

ǵԸҲҪѧϰİԼϽҲһѣ
رǲҽоԺԭʼ϶ղԼңоԺ
Ҳǿ 

ǵҩ˳ǧ˵ӦƳǵĹ϶ǵ
ɾ͡ѧſ͹۵ı׼Ҳͨ۽Ǵ 

 

ز 

Ϻҽо(1965) űר ϺƼ. 

ҽѧѧԺݣWg-5-4ɽŻҩѰңԷ
ɽĺϼƬĸõĹ۲죮1967.1 

л񹲺͹ѧίԱᡢйžܺڲ֪ͨ67
ʮֵ118šֵ388ţ´űҩоЭ顷Ҫ
űҩоЭ滮һ1967-6-16ԭȫ
ңϻ㼯ڲϣ2004. 

ҽоԺίԱ(1970)鷽ѡ࣮. 

ȫűо쵼С칫(1975) űоѧϳҩٴ
ר. 

ȫűо쵼С칫ңűоѧϳҩٴ۲ר
,1975-7 

ؽṹоЭ (1977)һ͵ıأѧ
ͨ 1977(3):142. 

Qinghaosu Coordinating Research Group(Эо)A new 
sesquiterpene lactone-qinghaosuChin Sci Bull(ѧͨ) 1977(3):142 

ҽоԺҩо (1978) ￹űо 19711978 

Ľƣշңϣջع,άƣ1979.
(Arteannuin)ĽṹͷӦѧѧ37:129-142. 

China Cooperative Research Group on Qinghaosu and Its Derivatives 
as Antimalarials (1982). Clinical studies on the treatment of malaria 
with qinghaosu and its derivatives. J Tradit Chin Med 2:45C50. 

China Cooperative Research Group on Qinghaosu and Its Derivatives 
as Antimalarials (1982) Studies on the toxicity of qinghaosu and its 
derivatives. J. Tradit. Chin. Med. 2:31C38. 

China Cooperative Research Group on Qinghaosu and Its Derivatives 
as Antimalarials (1982) Chemical studies on qinghaosu (artemisinine). J. 
Tradit. Chin. Med. 2:3C8. 

China Cooperative Research Group on Qinghaosu and Its Derivatives 
as Antimalarials (1982) Antimalarial efficacy and mode of action of 
qinghaosu and its derivatives in experimental models. J. Tradit. Chin. 
Med. 2:17C24. 

China Cooperative Research Group on Qinghaosu and Its Derivatives 
as Antimalarials (1982) The chemistry and synthesis of qinghaosu 
derivatives. J. Tradit. Chin. Med. 2:9C16. 

Meshnick, S.R., 1998. From quinine to qinghaosu: historical 
perspectives. In: Sherman, I.W. (Ed.). Malaria: Parasite Biology, 
Pathogenesis, Protection, ASM Press, Washington, DC, pp. 341C53. 

Meshnick, S.R., Dobson, M.J., 2001. The history of antimalarial 
drugs. Antimalarial chemotherapy. In: Rosenthal, P.J. (Ed.). 
Mechanisms of Action, Modes of Resistance, and New Directions in Drug 
Development, Humana Press, Totowa, NJ, pp. 15C25. 

ع (2009) ءʷʵʾѧչ 21:2365-2371 

Eckstein-Ludwig U, Webb RJ, van Goethem IDA, East JM, Lee AG, 
Kimura M, ONeill PM, Bray PG, Ward SA & S. Krishna S (2003) 
Artemisinins target the SERCA of Plasmodium falciparum. Nature 
424:957-961. 

Ž(2006) ٵı,, 㶫 

 (2009) ؼҩѧҵ 

ԥ, (2007) ҩűĻعչҽҩ
־ 28:46-47. 

˪ͰѪ 

ͤ,,,̫(1973) עҺ6Ѫ
ٴ۲.ҽҩ 1973(3): 66-67. 

Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, and Gemon 
M-F (1973). Acute promyelocytic leukemia: results of treatment by 
daunorubicin. Blood 41:489-496. 

ҽһԺҽƣҽһԺ (1974). 1עҺ֤
17ѪЧ۲. ҽѧ 1974(2):25-30. 

ٸ,ͤ(1979). ϸ԰Ѫڴ2. ҽҩѧ
־ 1979(6):31-34.  

ͤٸ(1979).һעҺ֤ƼϸͰѪ. 
ҽҩ 1979(4):7-11. 

ҽƴѧһҽԺҽ ָ:ִͤ: Ԫ  
μ:  ٸ   ϼ Ѫоң
1981һŽϱ֤ʩƼϸͰѪ73ٴС. 
ҽҩ 1981(4):28-30. 

ͤ 1982 ̸̸ҽٴеļ. ҽ
־2:180-181.  

ͤ 1983 ҽ԰Ѫʶ. ҽ־ 1983(3):71-74. 

Koeffler HP (1983). Induction of differentiation of human acute 
myelogenous leukemia cells: Therapeutic implications. Blood 62:709-721. 

Flynn P. Miller W, Weisdorf D, Arthur D, Banning R, Branda R (1983). 
Retinoic acid treatment ofacute promyelocytic leukemia: In vitro and 
in vivo observations. Blood 62:1211-1217. 

Nilsson B (1984) Probable in vivo induction of differentiation by 
retinoic acid acid of promyelocytes in acute promyelocytic leukemia. 
Br J Haematol 57:365-371. 

ͤ,Ԫ(1984). 1ƼϸѪٴֺʵо 
ҽ־4:19-20. 

ͤ 1985 Էܰϸ԰Ѫ֤. ҽ־ 5: 713. 

Daenen 5, Vellenga E, van Dobbenbugh OA, Halie MR (1986). Retinoic 
acid as antileukemic therapy in a patient with acute promyelocytic 
leukemia and Aspergillus pneumonia. Blood 67:559-561. 

Fontana JA, Roger iS, Durham JP (1986). The role of 13-cis 
retinoic acid in the remission induction of a patient with acute 
promyelocytic leukemia. Cancer 57:209-217. 

Huang ME, Ye YC, Chen SR, Zhao JC, Gu LJ, Cai JR, Zhao L, Xie JX, 
Shen ZX & Wang ZY (1987). All-trans retinoic acid with or without low 
dose cytosine arabinoside in acute promyelocytic leukemia: report of 6 
cases. Chin Med J 100:949-953. 

Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ & Wang ZY 
(1988). Use of alltrans retinoic acid in the treatment of acute 
promyelocytic leukemia. Blood 72:567-572. 

Ԫ,ͤ,,(1988). 1עҺ˸ΰϸɱ˶
ѧо. о 15:1-3 

,,,ͤ,ٸ,ջ,÷, (1991) 1
Žҽ֤ʩμѪڴ16. ҽҩϢ 
1991(6):39-41. 

,,,ͤ (1992).1Žҽ֤Ƽ
Ѫ32. йҽ־ 12:170-171. 

Sun HD Ma L Hu XC Zhang TD (1992). Ai-Lin I treated 32 cases of 
acute promyelocytic leukemia. Chin J Integrat Chin & West Med 
12:170-172. 

, ,,,쾴 (1992) ŶԼϸ
԰Ѫ(APL)߰ѪϸԵ.ʵѧ־ 
1992(2):29-30. 

,ϼ,,,ֻ,(1995).ƬΪƼ
Ѫٴо. лѪҺѧ־6:26-28. 

Huang SL, Guo AX, Xiang Y, Wang XB, HJ Ling, L Fu (1995). Clinical 
study on the treatment of APL mainly with composite Indigo Naturalis 
tablets. Chin J Hematol 16:26. 

,Ҷ,,ʩ,,,ѩӢ,ݷ,ӱ,ƽ,
ܽ,򾴣1996עҺ72ϸѪ.лѪ
Һѧ־ 17:58-60. 

Zhang P, Wang SY, Hu LH, Shi FD, Qiu FQ, Hong LJ, Han XY, Yang HF, 
Song YZ, Liu YP, Zhou J, Jin ZJ (1996) Treatment of 72 cases of acute 
promyelocytic leukemia with intravenous arsenic trioxide. Chin. J. 
Hematol. 17:58C62. 

Chen GQ Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, 
Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin, Naoe T, 
Chen SJ, Wang Zy & Chen Z (1996). In vitro studies on cellular and 
molecular mechanisms of arsenic trioxide (As2O3) in the treatment of 
acute promyelocytic leukemia. As2O3 induces NB4 cell apoptosis with 
downregulation of Bcl-2 expression and modulation of PML-RAR /PML 
proteins. Blood 88:1052C1061. 

Mervis J (1996). Cancer research: ancient remedy performs new 
tricks. Science 273:578- 

쾴,,Ө,,,ͥ(1997). 1Ƽ
ϸѪ20һ. йѪҺѧ־ 18:476. 

¹ǿ,,ʯѧ,ٺ,,С,ΰ,,߽,,
־,,,ͤ,G Claude,,,壨1997 յ
ϸѪϸӻƵĳо. лѪҺѧ־18:25-27. 

Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, 
Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, 
Naeo T, Kitamura K, Miller W, Waxman, Wang ZY, de The H, Chen SJ & 
Chen Z (1997). Use of arsenic trioxide (As2O3) in the treatment of 
acute promyelocytic leukemia (APL), I: As2O3 exerts dose-dependent 
dual effects on APL cells. Blood 89:3345-3353 

Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, 
Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, 
Zhang TD, Chen SJ, Chen Z, and Wang ZY (1997). Use of arsenic trioxide 
(As2O3) in the treatment of acute promyelocytic leukemia (APL), II: 
clinical efficacy and pharmacokinetics in relapsed patients. Blood 
89:3354-3360. 

Soignet SL Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti L, 
Corso, D, DeBalsio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell 
RP (1998) Complete remission after treatment of acute promyelocytic 
leukemia with arsenic trioxide. N. Engl. J. Med. 339:1341C1348. 

ͤ (1998) ҩưѪо̸̸1עҺ԰Ѫ
. йҽ־ 18:581. 

¹ǿ,,, (1998) עҺϸ԰Ѫ
ļ¼оչ. йҽ־ 18:581-582. 

ͤ (1999) ϸյֻ;. йҽ־ 
19:261-262. 

Zhang TD (1999). Studies on treatment of leukemia with traditional 
chinese drugs containing arsenic. On treatment of leukemia with Ailing 
No.1. Chinese Journal of Integrative Medicine 5:89-94. 

Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, 
Zhou L, Li JM, Zeng XY, Ou Yang RR, Yuan MM, Ren MY, Gu FY, Cao Q, Gu 
BW, Su XY, Chen GQ, Xiong SM, Zhang TD, Waxman S. Wang ZY, Chen Z, Hu J, 
Shen ZX, Chen SJ (1999) Studies on treatment of acute promyelocytic 
leukemia with arsenic trioxide: remission induction, follow-up, and 
molecular monitoring in 11 newly diagnosed and 47 relapsed acute 
promyelocytic leukemia patients. Blood 94:3315-3324. 

Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ & Chen Z (2001). 
Arsenic trioxide, a therapeutic agent for APL. Oncogene 20:7146-7153. 

Zhu J, Chen Z, Lallemand-Breitenbach V, de The H (2001). How acute 
promyelocytic leukaemia revived arsenic. Nature Reviews Cancer 
2:705-714. 

ͤ (2003) ˪. йҽ־ 23:65-66. 

Wang ZY, & Chen Z (2008). Acute promyelocytic leukemia: from 
highly fatal to highly curable. Blood 111: 2505-2515. 

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

йԺʿѡˮƽ빱Ӧøĸ

ߣTanPP

йӦԺʿѡƶȣҲйԼ׿Խѧɾ
˶ѡؼѡԺʿѡӰҿѧо
չķ꣡ԺʿѡԭΪ׼,ȱ

һԺʿԶԿ󣬹ʵڹڴ¸
ɿԳɼ̸һͬкѡԺ
ʿʱ˵Ǵĳĳѧᣬĳĳ־ȵȵԭ˵ǣ϶
ʮǰֵıһɣһƪ£ǵһߣ
֤ǳҪһƪµŵѡԺʿӣȱȽǣ
ԿѧĹ˵ĺĳĳɣ

ǣԽԽǷ˶ٸ£еǴоĸϵ
£Ҳ㣡ʲôѧᣬʲô־ʲôѧ飡
ЩȻ˵ѧףǲֱӵԭԳɹЩ˵ҳ
ϣоһͷΣ־֡ǣ˵ǶԿ
ѧԭ׵ʲô

Ҳ˻˵ǹҵĿѧˮƽˮƽҪЩԹ
ҿѧĹף90ǰԺʿѡͱѡϵˣû
ôSCI£ƺǵĿѧɼƷǳȻ뱾ͣ
ҶԿƼͶԽԽ࣬ԭԵĿѧɼԽԽӵ£
Ƽ籾ԭԿƼɹԽԽڷ־ϵԼ
һЩֱӵĿѧס´һϵƪ
ѧɾͣ漰ְƵȵȡǿѧ
飡һǲ֪ôԭԳɹûп۵ԭԳ
ǲȥΪ漰Ⱥ档еĹȥûSCIµԺʿ
ҲĻǣȡSCIһأһЩCNSºһЩӰӵ£
ܶڲоĺ󳾣֤˼ҵķֺۣԭԷ֣

䣬ڹڣͬһоɹҵλɣһƪ
CNSϣһƪרҵSCI־ϣǣǰ߾ޣ޲ܱйصλ
Ƶ!൰ǣӵϣû˼һ
ԭԿѧʶıǡǡǹĿѧţгɹܹͬʱ
Ƽ

һͻͽԭĿѧоδҷչ֧ţӦ
ȫ淢չÿӦߣҿѧˮƽ󣬸Ӧص㷢չ
еǰأʵѧרҡѧֻзչ׳
ԭͻƣѧƣֻд¼ʵĻԭԳɹܼѣ
ҪƣҲҪƫģҪеԺʿƵĺ޲
ĿͲÿܵʵҶо

80µԺʿԺʿѡʱҪٶķ־
ϵѷ˼࿪죬ϸѣĸɹ
ԭԣڸ磿ÿѡˣֻһԭԵĳɹ
ԭľ͹ˣļӹף쵼ôĿ
ְʡַȶѾ֣

Ҹĸ￪30꣬ԿѧоѾͶ룬Щѡ˶
ߣȹͬеʵãӦ׼Щ˵Ŀ
ѧˮƽĺ͹׵ģֻۣŻҹԭоѸ
չѧȤԴԺ¢ԵĿѧоԭ
ɹȰѧоߡ

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

廪ѧڵѧУġ̡

ߣ

廪ѧѧԺѧίԱḱΡϵѧίԱΡʿʦ
ڣжصѧˡдٱŽҷ廪ѧй
쵼ʵڲˣκδ廪ѧġ̡ʵǲ
Ϊݡ뷽ڡ˿ع⡣

ѧ˵ʵУٱڡйڿȫݿ⡷
鵽
һ
A. ˼ȫ۵Ľ ˼ʵ˫¿2003
1
B. ˼ȫ ˼ѧо2004߼

BAĸƣ֮ͬBժҪ͹ؼʣ6װ任
ۣͼ


A. ȽѧѧƵġ롰 ˼սߡ20055
B. ȽѧѧƵġ롰 Ļۡ20061

ABĳŰʽͬ⣬ĿһֲֹĿŵֱ


ʵǱɽһǡʱͬвȽһڱĴ
ʵ˵

ʱ˼ ѧ2005
ʱй۵Ĺʻ۽ ѧѧ(
)2010

ѧ뷭 о2009
ѧаʵ ̽2010

뷭۵Ľ⹹һʦ й롷
2005
⹹ʾ˼ 廪ѧѧ(ѧѧ)
2005

ĻĻоķѧת й롷2005
ĻԪĲ й롷2005
ѧۻѧƵӽ й롷2006
оĻת򣺽⹹ƽ 廪ѧѧ(ѧѧ)
2009

ȫ򻯡ĻоȽѧо йȽѧ2001
ȫ򻯡ĻойѧߵĻ йĻо2002
ȫ򻯡Ļо͵۵ ѧ2005
ȫ򻯡ĻоȽѧ ѧۡ2007

ѧĻѧ̬ ѧо2005
̬̬״δǰ Կ2010
̬ѧ̬ѧ⹹뽨 й롷2011

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ǧ˼ƻѡ

ߣ

Ŀǰһǧ˼ƻѡѾʾȻǧ˼ƻѡι
è壬ĳЩѡ󣬻Ϊ𾪡һ
ҿһ

廪ѧ ޿ 19802  [Ӣ]ţѧϵ оԱ
web of scienceѡߵģ£
(1)    Optical studies on a single GaN nanocolumn containing a 
single In(x)Ga(1-x)N quantum disk : Holmes Mark J.; Park Young S.; 
Wang Xu; . Դ: APPLIED PHYSICS LETTERS  : 98   : 25     
׺: 251908   DOI: 10.1063/1.3601856   : JUN 20 2011 (ھ)
(2)    Carbon nanotube nanoelectronic devices compatible with 
transmission electron microscopy : Wang Huiliang; Luo Jun; 
Schaeffel Franziska; . Դ: NANOTECHNOLOGY  : 22   : 24   
  ׺: 245305   DOI: 10.1088/0957-4484/22/24/245305   : MAY 
17 2011  (ڶ)
(3)    Carrier dynamics of In(x)Ga(1-x)N quantum disks embedded in 
GaN nanocolumns 
: Holmes Mark J.; Park Young S.; Wang Xu; . Դ: 
JOURNAL OF APPLIED PHYSICS  : 109   : 6     ׺: 063515   DOI: 
10.1063/1.3558990   : MAR 15 2011 (ڰ)
(4)    Response to "Comment on 'Ultrahigh secondary electron 
emission of carbon nanotubes' " [Appl. Phys. Lett. 98, 066101, (2011)] 
 : Luo Jun; Warner Jamie H.; Briggs G. Andrew D. Դ: 
APPLIED PHYSICS LETTERS  : 98   : 6     ׺: 066102   DOI: 
10.1063/1.3552976   : FEB 7 2011  (һ)
(5)     Ultralow Secondary Electron Emission of Graphene  : 
Luo Jun; Tian Peng; Pan Cheng-Ta; . Դ: ACS NANO  : 5   : 
2   ҳ: 1047-1055   DOI: 10.1021/nn102579f   : FEB 2011  (һ
)
(6)     High-Performance Field Effect Transistors from Solution 
Processed Carbon Nanotubes : Wang Huiliang; Luo Jun; Robertson Alex; 
. Դ: ACS NANO  : 4   : 11   ҳ: 6659-6664   DOI: 
10.1021/nn1020743   : NOV 2010 (ڶ)
(7)     Ultrahigh secondary electron emission of carbon nanotubes 
: Luo Jun; Warner Jamie H.; Feng Chaoqun; . Դ: APPLIED 
PHYSICS LETTERS  : 96   : 21     ׺: 213113   DOI: 
10.1063/1.3442491   : MAY 24 2010 (һ)

ѡ߽3ƪһģһƪȻResponseġѧ
ҵȻ˳ѡǧ˼ƻ֪ǧѡߺ׼
ǧ˵ĺкθ룿

ŵһǧ˼ƻѡлƵġţˡλھ
Ҳ뷽עһ´¡

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ȫְڿNSFCϡɽࡢɽʡ̩ɽѧߺƸ

ǹȡʩӭ֪гźˮƽĿѧԲͬʽΪ
ڵĿзչ񣬵Ƕڡͨԡ͵ǲӦüֹ

ൺһλţˣ

1. ɽʡƸڣ
http://news.qust.edu.cn/html/2007/2010_01_101610262523636.htm Ҫ
ٹ36£

2. ɽࣺ2011JQB01027 壬̼׹ܲ
зൺƼѧ Ҫ󣺡ɽʡй̶ƸλƸڸǸ
ִޣÿʡڴоʱ䲻¡

3. NSFCĿ51172113/E020603ʯīϩȼϵش߻
ĿɿƱ߻о壬ൺƼѧ58ʵʩޣ
2012-012015-12
Ҫʲô˿ȻѧĿ
ѧȫлصߵѧУΪ»
оĿԱͨڵλ롣
뵥λӺʽƸεĿԱ⼮ۡر
̨ĿԱƸڸĿִڣÿڹڹʱ
9£ͨƸελĿйع涨ΪĿ
Ȼѧ𣨲ҽܳѧĿʱ
븽 뵥λ²ųߵƸЭĸӡЭ
ĿλΪƸελ֪ʶȨе⼮
ۡ ر̨ĿԱйزź˷
ר֤ר֤ӡ

4. ְλhttp://physics.missouristate.edu/Dr-Dong.htm
ڹʱûƣɰĽ

ൺơ

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ݾüѧкʿΪٱ

дݾüѧкĵľٱš

ã

ȥ10ɻѧUniversity of Iowa
jusan.yang@gmail.comġҩĿºҽͣҩеȫ
ٴ鼰񡱵Ŀں˲Ŀܱ 
www.hccper.gov.cn/pic/2010101114131557.xls鹹ݣ
2008ױгŰ칫ңORINIHվ
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-014.html



Ϊ

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ڡʦƳ ʦ±١һĵĲ

ߣ±

ʦƳ ʦ±١һķӳʵ
ڱʦУ԰ѲšֻǴΪ˹ȫѧУ˭ҲԸȥ
Ҵһѱľع⣬ٲʵٷ鴦
ʱο

1.ȷʵһλصصġ⡢㾭ѡָڽڣһ
ʦ¹ĲʿΪ֤Ȼ2009ȡòʸ񣬵ȴ
֮УΨһԭǡ⡢㾭ѡᡢ
һλ²ȴѾʽ

2.ٷʽƭȡʦ±ƺ֮˹ְ
ǿҷС쵼ɲ˲ʱ˼ѧԺĶʦλ
¿ơʦ±֡ϸ񡱣ʾͷŭǣȴȫ
⣬ȻٴνʦΨһһö2011׶Ͷ¡յ
ǰ¼ϵĵһ仰ȻǡֺͲμӹҺʡп
⡱

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ѣΣ

»籱£յ

»С

    кͷչͳĻӦ澫ȥɡѪࡱع⣬ǡǷ˼
šʱ۹ʣ֮пѧֶ޷ȷ֤
ҵ֮סȴԶ׼

һЩΪһļȣҩġȻ˵
ȫûǿĿѧ֤֧֡ꣷ£ôŶѧ
ũѧԺĿѧұ˶԰ѺѪѵӪֵ
Ҫɷǵʺ̼ˮǰռصģռ
Ӫɷ뼦Աȣûơ
кѰ׵סѻ׵׵ȶֵʣзḻάأάأ
Ͷֿʡ

ôѧһ˲ֶͯѺعԭо
УѧҶˣˣĵס뼦еƣշ
Ӧ

    ѵƷУв̼ѻбƤӵ
ʡǣĿǰûϸĿѧ֤˵

ѵʳЧδȷ֤͵гշ
ѵĽߡ˿˹ࡱҵ˽ը


    ѵʹѼ۸ԾҰ˿Ͼ
ΣӡķȻʷĵĿѧڣĩѲ
ذưȺʵؿ졣Ƿ֣ڣĽ˿෱ֳ
ص˲ɼѵжǣͳƵУֻв
ڣ䣬ؽ˿½ˣϡ

    ң˹ֳѴΪ˲ظɽѨɼѣ
ҵ߿ʼ˹ೲͨͬ˿סǡࡱ
Щ˹ೲУȺ˿ͳһص㼯нʳˮϴ衣Ȼ
Ļھ޴ա֮ĽӴƵ
дĿԼӾ硣Σ˿ˮӷֳص㣬
ʹ˹ೲΪȴȵ㡣

ֻ֮޵Ĵ˵֤֮ȷṵ̂û
ţûû˺ֺη꣩

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ҽǵʶԴ

ߣŹҫ

ҵĲˡҩˮԴˣһЩ
ҽסˡһ졣һǣ
ûҽ֮ǰйôһǣҽҽûа취ģ
ҽа취

ʵõòõˣܹϵͳĶҵȫ
£ʵҶѾشˡʵڲҪٷ׸ʡ

һ죬ϸ30ɳʸ˹
ġ˹еǳȡĴ𸴴˼ģѵҽй
ģûҽ֮ǰйôأ

ʵϣʷݱ俴й˺ҽҽ
ˡ߲Ƶھĵһƪһ仰˵Ϲ
֮ˣԶȰꡱ㿴ûҽʱй˶Իһꡣ
ҽԺ󣬷˻ʮϡˡԼԼ͵˵
ҽô˼̸ҽй񽡿֤ʷף

ʶԵⱻ80ˣڻʣʲô˼أ

ڶЩҽұģҽûа취ҽҲûа취ģ
ҽа취

ƵʣҾ˵ÿ춼У¹Ҿ
ľ֤ʵһ֥ùӵ⡣ЧơҪ
˫äԱʵ۲ȷϡδȷϵġЧЧҽѧ̸
ֵĻ緶Χ˵Ҳ˵30ˡҽǾӲ
ñѼڹӶΪˣͻӲ
ûû˵ؾ⡣21Ͷȥ11ͷˣҪੲ
ݵ˵һΡҪҽ˵Ķû룬ҵ
Ѿµ÷أ

һҽʿףûҽ˲ҩ֮ǰ
νǲ֢֮˷νˣвҲ˵ҽ˲
ҩ֮ǰ˵˷νˣҲͬвôڴ֮ǰ
ҽην˵أ

Ҹڷù֮ǰ˶Խ˲˽ǿӪ⣬ȷ
޲ߵġùطԺ󣬽˲Ѹٽַ͡
¡ƽЩҩ﷢Ժ󣬽˲޿ɾҩľõ˼Ĺۡ
ǣʹЩҩҪڶȽϳ꣬ꡣǶ
ʹ߲ҩԡʹý˲ȻһָյļԣĿǰ
ҽԸ˲Ļָ˼ǼǿߣδȻ˽˲
鷳ġ

û뵽ʵǵĻش𣬷·λҽʿץˡ
Ȼ¼ǰõӻ죬ظǵġҽ
ҽûа취ģҽϺа취һס

νҽҽûа취ģҽа취漰һЩܻ
ĸѾ˵ùء¡ƽǿԸν˵ģ
ĿﾹȻðһҽû취⣬а취ڰٷ
֮ٶа취ͬ͡ĸùء
¡ƽӦÿԱΪҽа취ûκ˵
Щ취Ϳý˲߸ˡ㷭ҽ׿һһ
ӦӦ˲һָ㣬ĿǰΪֹ˲Ȼһ
߷ռǰһ仰൱ڸ㡰а취һ仰൱ڸ㣬
Щ취һʧ

Ѽϣ2009꣬ȫ˲ģ

֮壬
֮һ
к֮ߣ
֮ߣ
̫ƽ֮һ
ȫƽ֮һš

Ŵ˲λİٷ֮ƣڽһλһλ
֮ˣҽҽԽ˲û취治֪ҽ
û취ôġҽа취ĻҲóһʵ
ôҿһһòãṩĸ˫äۣ
̸۵ġͳЧûͳ˵Ҫ˼ôġҲа취
أ

΢еѧ˼άͷԵĶжϵóҪʹҽҽֱûа
ģҽа취ԳӦĵʵ飬ʹЩ
Ľ˲ʽ磬й̫ƽҪȷҽ
ƽ˲ҽҽãͱóȷʵ֤
ҽϷ룬ʹҹ˲ߵʽ֮һžžŵ
ˮƽǾͿԼҽ϶Խҹ˲ߵʹ
֮һҽϡЧȫпѾ
ҽа취֮ˡֵ׷ʵǣȻõǡҽϡ
ʲô֤ݿ֤ġЧҽϵġҽ֡
ҽ֡ҽϵġϲ֡

˳ʶԵĶʵڲ̸ǣЩΪǶ޲
йˣֲò̸Ҳΰһɣ˭
йأɣ̸ĶͶ̸÷ˣҪ
̸

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

ҽѧĹϵ

ߣ걣

ڷӡҽαѧ۵ķеڣΪЩ˲
Ǻ˽⡰ѧ򵥵Ҳһֱ۲ݡ

ʦҽαѧһ۵ǰġȷˡҽ
ڿѧߡһҪҽ˵ڿѧ⡰α֣ǡ
Ϊǡ˼ҽԳΪѧ仰ɸĵòôۣ
ҽǿѧɡ
ԺĻǡҽڿѧ⡣

һѧֻһ֪ʶϵ

ѧһ֡ȷȽĴʣһݴʣ
һ˿ĶһҹϵϵҶϵϵ
оγ˿ѧϵϵҪΪѧƵļ壬
ѧ ѧ ѧ ѧ ѧ ѧ ȵȺܶѧơ˵ҽѧ
ҽѧֻǶҽǷϵһ۰ˡڲ
ϵȷûûбȻϵ˵ҽѧҲǶҽ
ķ񶨡

ִѧԴͷԹϣȻѧŷոʱڵչ
Ȼȫ紫ġԼڹԪ1300֮󡣶ҽϵ
ıҽĻ֮ϣƵھ˺ӲۡѾ
ũݾˡ˺ӲۡȷΪĩپ
߶꣬ʱ䶼ʱڡ˺ҽ۱仯󡣴Լ
ڹԪǰ100ҡԶ׼ҽڿѧϵ֮ǰͳˡ
һȳֲб仯ҽǿѧϵһԱ

ǿҲáҽǿѧֻҽ뵽Լ
ֵ֪ʶϵҪҽѧһϵɲǴһͿԵġ
ѧϵͳѧƣѧ ѧ ѧ ѧ ѧ ѧ ֮
࣬ѧصģҪѧҽܺЩѧ֤ʵìܣ
һìܣҪôҽԣҪǸѧƶԣһҪó۲С
Ϊҽûüѧϵ׼Ĳ˵ΪҽѧĻ
ṹܵĹ۵㣬ҽԲ롶ѧѧȷ
һ¡ҽѧʱա

ѧԵǿ͹۵ʵ

ѧǽڿ͹ʵĻϣѧΨģΨĵġҪ
ͨʵ֤ѧ۵ʵԣϿŵʵʵ顣ûʵûп
ѧٳĶѧҪʵġûʵû˵
޷֤κζȻѧкܶûбʵ֤ʵĳΪ˵
˼дʵ֤ʵǲҪ֤ʵ

ʦμӵӽĿҶ뷽ݵҽǴ˵
ҽѾ˼ǧʵ֤ȷԣѾҪ֤ˡ˲
ѧǳв֪Ϊμǧʵ֤֤ܵҽȴҪ
꼸µĿѧʵĪʵ֤ǡѧɡıҪթҽ
ʧܣ

ֵΪǧڵʹҽҽǺʵ飬
ʵʹˡ˵ʵ飬Ǽ򵥵ʵȻʵҲֻʵ
ϱ׼ƹʵȵʵ˵һҩȥ
ˣֱ۵Ķڿѧ˵κ⣬ǡԼ
ˡҩáá󡱻ǡҩáҪ
ƺʵıúö飬ʵ飬Щܵĸضų
СⲻΪҩĲζƫֻҪÿѧо
Ƕô̵ģκһֿܣҪǽȥ

ҽҪͿѧϹϵһҪʵ飬һҪ֤ҽӦǿ
۵ʵҽִҽѧӹйѧҺܻҽҩʵ飬
Ҫҩʵ顢ʵȣûҽ۵ʵ顣
һλҽ˶ʿ˵ҩо˺ܶ࣬кܶɹЩѧ
˵ѾҪ֤ˡҵĹ۵ǣ֤ҪôҲ취
֤ҪôԹ֤ȴ֤αˣԶҲ취֤Ķġ
ʵҽؼĶȥ֤ȥ֤һЩҪĶҴ
ʧˣֽҽо᱾ĩʵ

һʵйôҽҩʵ飬ûа׷ѣΪ
ʵĽʧǡ˵ҽ۵Ĵ

ѧʵ֯

ѧǿҸԵֱ£оôѧôˡÿҶ
ԼĿѧ֯ҵĿѧ֯ҲǶģϵġһЩ
ʵı׼ȫͳһı׼

˵ǵҩѾٴʵ֤ͨˣ֤ҵҩ
ЧġȫġĪ֪йҽҩĹȡǷſ˵ߣֻҪ
ҩҽҩͿԲܶҩҪʵ飬ʵҪﵽı׼Ҳή
ͺܶ࣬ҩҩ׼ǲͬģҩŴġǿֱܺ۵ؿ
йгǧҩгҩһҩû׼ΪҩΪ
ҩκŴڲŴı׼ǰҩȫû

Ȼȴ˵ҽΪʲôҪν׼Ĺ涨ǹҵı
׼ѾܴﵽˣҩİȫЧȻ֤ʵˡⲻԡѧı׼
ģҲ㡣ʹͬ׼ı׼涨һҩʵ
Щһڶ֮Ķȷ涨Ҫôֻͨ˹ʹͬ
׼ģǴﵽѧ׼ġҪı׼ֻǹҷɵĹ涨ֻҪ
ﵽҷɵı׼ˣҾڱٴҩйͨˣ
Ҳδصͬܡѧһʵ֯ȫĹϡйҩ
йҩĹ׼ǲʵġܡϡĽǣҩֻй
ܣһ⣬ֻߡʳƷС· йǱ
֪ҩľ水աҩı׼Ҫҽҩҽ
Ѿ군ˡ

ĵ㣬ѧɱ֤α

ѧǿ֤αģʵ޷֪һѧǷһȷ
ѧвдʱǿϽȷ֤ⲿֵĴ
ѧʾǺϺѧѧʡһѧһʼͶԼΪȷģ
֤αҲܾ֤αֻܵʹã֪ʶǳΪ
֤α֪ʶ֤α֪ʶǲϿѧġ

ţһɣڻȻԵͼ֤
޷ҽͷβԸ⳥֤αԼҽ¡

ֿܣҽķǻ۾ԶǧǰƵ۾
ܱ֤ԱȻⲻģҲһ㣬Ժŵһֱ
šֻܼо۶ԴĻΪҽѾͿѧ
ɵĶͬһˮƽΪѧĶҽ
ǸĶĸǴģҽʹеҲԲǴ
ںĵҽϡ

ҽ֤α֤αһʵ֣ҽһ޴
ұ˺ڴҽѧԼؿԼֵĶ
֮ʹƲѧ޹أҲҽĽҽ
ܶ࣬һĨɱҽȴ࣬ӦǺɸֵˣǻ
ٶҽһЩ⣬֤αǿչҲһĳԡ

Ҳҽ֧Ϊҽڿѧǡпѧԡġҽķ
ЩɷֵȷÿѧۺʵȽ֤ġ˵ľ̶
Ĵ̼ﵽӦͲЧֵעǡҽĿѧԡƬ
ģҽҲͼÿѧ͡С֮࣬Ϊ
ҽĹ۵ҽҽԼصۻ
̣һͶȴֻԸһӵһȫû
ǻᾡֹ

ѧһѧƺһѧƵĹϵɲҽѧ
ҽ֮಻ǡҡֻġһҡΪѧƶ
ʵΪݣʵΪĿĵġʵľǶԵģʵľǲ
Եġ֤׼ʵ飬ǿ͹ʵҽȻ޷ܾѧƶ
ǷʵʡѧʵȴʵӦõ
ڡҽ޷ֻԼġͿѧҹ

ҽѧԲݣǿѧѧϵһ
ѶȣԸ޴ĸı䣬ҽĿѧһ̶ȣȴġ

˵һ䣬Ϊҽڿѧ˵ľġ
ҲҪҽͿѧΪһ̸ˣֻٴ˵ǿеҽĿѧ
ֻǡαѧ

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

̸̸ӴٵġΧ

ߣƽ

о֣ͬ־ʮٹУרġ
ٹ硱˵塱˵ٱζ˵ܾˡۡ
С۵ȣЩ˵ԡƵơܴˡѵ
ġͼѴѧۡ߶ȣΪͬ־ṩο
ָ˴µĴҵ

һ֮д٣ҪʱμǡҪ˼룬עȺ
ΪġܻӭĹ⣬Ⱥϲּڽܵķʽ
֮֮롣ΪҪ岻Ҫԭ

Ҫ

һҪעйȵѵ㣨ûǡС

١졢ͯաȼ۹ߡθĸȵȣͳ
ͳҪ롰ѧٶʿķۣҪûҲҪ
ڵҲίԺԺʿҽѧƭӡ̾޼ЩӬò
֣˵ҲҪ׷ﵽBBSƵĸ߶ȡ

Ҫʵ¶ѧθ

ļ٣ӡ֮ӣĸܡҲҪ
׳ʿûСѧ족ûƽȫѧ淶ϵ
ڿ֮ڡ

Ҫش

ԱŷɽӢбҡսƵȱʾģ¶
ѶϢۣǵĹҰͶǻۡ

ߵıҲʮҪϴԼҪڹ60%30%
10%Ϊˡ

岻Ҫ

һҪ빫֪㣵֪ʶ

տգҪ߶ȾС΢ʳûӡªϰ
𽡿еҲ˵Ҫ˵ҿִҪǸİǰ϶
ҪΪˡڹ㳡ϰװ׵

Ҫѧǵļ

ѧ֮ܳΪǣһв׵ı֣һ˵Ļ
й㷺ȺںƽѧڵȣйҲָ
Ǳǵϰա

Ҫֽ˵

ֽǴȾףи䣬ͷ˶಻Ϥѧɲ档
ѡŰɵǣ˿ȥɣ
Ȼ᳤ġִ֧١ͬԼǣܺǽ
ѷԷԼͲǡʹߡˡ

ġҪ̽ɹʿļ

Զ׼ɹʿɹˣΪһġʦ͡
ǳڵɷ񶨣ǶԹ˰յĹײĨɱʷƿթƭ
ҲǶԶǼʹȫˣҲһɵ˰ࡣ

塢Դҽڽ̡תʱҪƫ

ҽֱۣΪαѧӦȶҽľѧĹ׿϶
һһίָ䡰㡱ǿǵת
ҪԷԵ˺ƹ˸ʮ壬ӦᳫضԴȫΪ
ֳǵġ͹ۡ͡

ôܻϲᣬͬ־ѭҪ岻Ҫ
ԭȷķΧ٣ܶԵеУԵʮй
ڴĿ⣬öȺڡ͡ʹ⣬ηķԣӮ
֧Ӧһ˵дСֻҪЩɣһ
ˣһƫִˣһ̸ߵˣһɷĹΪġ
ˣһˡ



2011.8.23.

(XYS20110824)

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

һΪ˰޷˿վĹ˽˿վĶ̬ؿ
˿ʼбxys@yahoogroups.com

ʼбÿ췢һ˿վ¸µϣÿµ׷һÿ
Ŀ¼ʼбĶμ롰˿֮ѡ
ʼбxys_friends@yahoogroups.com

ù䶩ġù䣬ܿ޷յ
Ƽ䣺yahoo.com, hotmail.com, gmail.com

ġ˿ʼбĵ䷢һհż

xys-subscribe@yahoogroups.com 

塢ͣ˿ʼбͣ䷢һհż

xys-unsubscribe@yahoogroups.com 

Ͷxinyusi@yahoo.comôıļͶ塣

˿(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)

